JOPHON NCPD (2024 Jul/Aug) Improving 1-Deamino-8-D Arginine Vasopressin (DDAVP)

Challenges in Pediatric/Young Adult Patients with Bleeding Disorders: A Quality Improvement Study

This course contains 3 sections:
1. Article
2. Post-test
3. Evaluation

Learning Outcomes:

1. Recognize key drivers that led to Desmopressin (1-deamino-8-D-arginine vasopressin) (DDAVP) challenge errors.
2. Understand the importance of timely lab draws for patients receiving test doses of DDAVP.
3. Identify barriers in obtaining appropriate laboratory testing after the administration of the DDAVP test dose.
4. Integrate interventions that demonstrated a reduction in errors DDAVP challenge errors.
5. Analyze and report data obtained following the incorporation of interventions to reduce DDAVP challenge errors.

4. Describe the benefits of pre-briefing and de-briefing in simulation education on end-of-life care.

Credits

Upon successful completion of this course, nurses will earn 1 CNE. There are no pharmacology hours associated with this activity.